Were Analysts Bullish Ricardo plc (LON:RCDO) This Week?

Alicia Cross
April 20, 2018

Debenhams plc, through its subsidiaries, operates and franchises a range of department stores in the United Kingdom, the Republic of Ireland, Denmark, and internationally. Its up 0.45, from 0.95 in 2017Q3. 7 funds opened positions while 6 raised stakes.

Panagora Asset Mgmt has invested 0.01% of its portfolio in Ashtead Group plc (LON:AHT). Argi Investment Svcs Ltd holds 0.02% or 62,107 shares in its portfolio. Vantage Investment Advsr Limited Liability Company invested in 0% or 384 shares. Prudential Public Limited Co invested in 20,900 shares. Federated Investors Inc Pa reported 678,120 shares or 0.01% of all its holdings. Whittier Tru accumulated 8,152 shares or 0% of the stock. The stock has an average rating of "Hold" and an average target price of GBX 641.25 ($9.18). Schroder Inv Management holds 0% of its portfolio in Ashtead Group plc (LON:AHT) for 23,168 shares. Quantum Cap, California-based fund reported 43,273 shares. The Somerville Kurt F holds 131,854 shares with $17.29M value, down from 140,254 last quarter. Invesco Limited has invested 0% in Croda International Plc (LON:CRDA). Venator Mgmt reported 3.75% in Sky plc (LON:SKY). Pacad holds 0.15% or 4,100 shares.

Since December 11, 2017, it had 0 buys, and 6 insider sales for $10.63 million activity. GENDELL JEFFREY L ET AL bought 48,966 shares worth $831,711. The stock decreased 0.24% or $0.17 during the last trading session, reaching $72.12. About 167,790 shares traded. About 3.01 million shares traded. intu properties plc (LON:INTU) has 0.00% since April 19, 2017 and is.

Man City fullback Walker: Pochettino makes Spurs title contenders
However, Tottenham could only manage a draw against a Brighton side who moved a step closer to top-flight survival. Albion drew level when Pascal Gross slotted home a penalty awarded for Serge Aurier's foul on Jose Izquierdo.

Toronto Blue Jays vs. Kansas City Royals
Jamie Garcia (2-0) earned the win, allowing three earned runs on eight hits over five innings, while fanning five and walking one. Making his first start of the season, Joe Biagini allowed three runs on six hits, striking out four, in 5 2/3 innings.

Overtime Finally Bites Blue Jackets
The Capitals took the lead back on a John Carlson power-play goal with 5:17 left in the middle period. Absolutely, the crowd will be loud for the Blue Jackets to neutralize the visiting Capitals.

Be Heard Group PLC (LON:BHRD) had its price objective hoisted by equities research analysts at Numis Securities Ltd from GBX 4.46 ($0.06) to GBX 4.91 ($0.06) in a research note issued to investors on Monday. Therefore 55% are positive. Ei Group has a one year low of GBX 118.20 ($1.69) and a one year high of GBX 153 ($2.19). The target price gives a possible downside of -4.98 % from firm's last stock close price. QinetiQ Group PLC had 10 analyst reports since November 16, 2017 according to SRatingsIntel. On Wednesday, March 14 the stock of Burford Capital Limited (LON:BUR) has "Buy" rating given by Berenberg. The rating was maintained by Numis Securities with "Hold" on Monday, October 30. The stock of XP Power Limited (LON:XPP) has "Buy" rating given on Monday, April 9 by Peel Hunt. The company was maintained on Friday, August 28 by BMO Capital Markets. Finally, Citigroup reissued a "neutral" rating and issued a GBX 30 ($0.43) price target on shares of Debenhams in a report on Friday, January 5th. The rating was maintained by Deutsche Bank with "Hold" on Friday, November 3. The company was downgraded on Tuesday, January 23 by Morgan Stanley.

Among 32 analysts covering Hewlett-Packard (NYSE:HPQ), 16 have Buy rating, 0 Sell and 16 Hold. As per Friday, February 24, the company rating was maintained by RBC Capital Markets.

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. Cornerstone Cap Management Ltd Company accumulated 24,300 shares. The firm is developing OV101, a drug candidate that is in Phase II clinical trial for adults with angelman syndrome; and Phase I clinical trial for adolescents with angelman syndrome or fragile X syndrome, as well as in preclinical development stage for pediatrics with angelman syndrome. It now has negative earnings.

Other reports by Free-Prsite

Discuss This Article